Lexaria Bioscience Corp. (NASDAQ:LEXX) | WebDisclosure

Basculer en Français

10161	Companies
208736	Keywords
138859	Articles
110648	Press releases

Headlines Articles Press releases Lexaria Bioscience Corp.

Home
Companies
Lexaria Bioscience Corp.

BRIEF

published on 12/23/2025 at 15:34, 3 months 12 days ago

Lexaria's Phase 1b Study Achieves Primary Endpoint

Drug Delivery Innovation Phase 1b Study Lexaria Bioscience DehydraTECH-semaglutide Side Effect Reduction
BRIEF

published on 12/23/2025 at 15:34, 3 months 12 days ago

L'étude de phase 1b de Lexaria atteint son critère d'évaluation principal

Innovation En Matière D'administration De Médicaments Étude De Phase 1b Lexaria Bioscience DehydraTECH-semaglutide Réduction Des Effets Secondaires
PRESS RELEASE

published on 12/23/2025 at 15:29, 3 months 12 days ago

Primary Endpoint Successfully Achieved in Lexaria's Phase 1b Study GLP-1-H24-4
Lexaria Bioscience Corp. announces DehydraTECH-semaglutide shows significant reduction in gastrointestinal side effects compared to Rybelsus®, with recent financings enabling new 2026 development opportunities

Financings DehydraTECH-semaglutide Lexaria Bioscience Corp. Rybelsus Gastrointestinal Side Effects
PRESS RELEASE

published on 09/21/2023 at 15:10, 2 years 6 months ago

Lexaria to Evaluate Impact of DehydraTECH on Oral Performance of GLP-1 drugs used in products such as Ozempic, Wegovy and Rybelsus, Alone or Together with DehydraTECH-CBD

Accesswire

Published on 04/02/2026 at 22:00, 2 days 1 hour ago

Star Copper Announces Closing of Charity Flow-Through Unit Private Placement
Published on 04/02/2026 at 18:32, 2 days 5 hours ago

Datavault AI CEO Nathaniel Bradley to Present DataValue(R), DataScore(R), and Information Data Exchange(R) Technologies at XRP Tokyo 2026
Published on 04/02/2026 at 15:00, 2 days 8 hours ago

Jaguar Health Family Company Napo Pharmaceuticals Co-Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress
Published on 04/02/2026 at 14:40, 2 days 9 hours ago

Northfield Capital Completes Acquisition Of Additional Interest In Juno Corp. And Announces Issuance Of Class B Multiple Voting Shares
Published on 04/02/2026 at 14:30, 2 days 9 hours ago

Worksport Announces COR(TM) Portable Energy System Is Now Fully Certified, Including Key UL and CSA Approvals, for North American Retail and Commercial Distribution

View all ACCESSWIRE

EQS Group

Published on 04/04/2026 at 10:07, 13 hours 33 minutes ago

Heidelberg Pharma to Present Data from its ADC Technology Platform at AACR Annual Meeting 2026
Published on 04/04/2026 at 02:05, 21 hours 34 minutes ago

Blokees made its debut at 2026 Thailand Toy Expo, exhibiting multiple products
Published on 04/03/2026 at 18:00, 1 day 5 hours ago

IEVA GROUP: IMPLEMENTATION OF A LIQUIDITY AGREEMENT WITH CREDIT INDUSTRIEL ET COMMERCIAL
Published on 04/03/2026 at 18:00, 1 day 5 hours ago

IEVA GROUP: MISE EN OEUVRE D’UN CONTRAT DE LIQUIDITE AVEC LE CREDIT INDUSTRIEL ET COMMERCIAL
Published on 04/03/2026 at 17:45, 1 day 5 hours ago

Atbash Launches on Chromia to Enable Verifiable, User-Controlled AI Systems

Les Echos

Published on 04/03/2026 at 18:46, 1 day 4 hours ago

Disclosure of Share Capital and Voting Rights as of March 31, 2026
Published on 04/03/2026 at 18:46, 1 day 4 hours ago

Déclaration du nombre d’actions et droits de vote au 31 mars 2026
Published on 04/03/2026 at 18:01, 1 day 5 hours ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 04/03/2026 at 18:00, 1 day 5 hours ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 04/03/2026 at 18:00, 1 day 5 hours ago

LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 mars 2026

View all LES ECHOS COMFI WIRE